Central Admixture Pharmacy Services, Inc (CAPS) announces the launch of its service for the admixture and de- livery of Hibernation Therapeutics’ patented Adenocaine microplegia, a low-potassium, non-depolarizing cardioplegia solution. Adenocaine solutions from CAPS arrive prela- beled with CAPS high-contrast labeling to maximize legibility and usability in the operating room, and with tamper evidence for added safety.